- Home
- CVKD vs MNY Comparison
CVKD vs MNY Comparison
Compare CVKD & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- MNY
- Stock Information
- Founded
- CVKD 2022
- MNY 2014
- Country
- CVKD United States
- MNY Singapore
- Employees
- CVKD N/A
- MNY N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- MNY
- Sector
- CVKD Health Care
- MNY
- Exchange
- CVKD Nasdaq
- MNY Nasdaq
- Market Cap
- CVKD 29.5M
- MNY 31.9M
- IPO Year
- CVKD 2023
- MNY N/A
- Fundamental
- Price
- CVKD $12.71
- MNY $1.06
- Analyst Decision
- CVKD Strong Buy
- MNY Strong Buy
- Analyst Count
- CVKD 1
- MNY 1
- Target Price
- CVKD $32.00
- MNY $4.00
- AVG Volume (30 Days)
- CVKD 36.2K
- MNY 213.8K
- Earning Date
- CVKD 08-06-2025
- MNY 06-13-2025
- Dividend Yield
- CVKD N/A
- MNY N/A
- EPS Growth
- CVKD N/A
- MNY N/A
- EPS
- CVKD N/A
- MNY N/A
- Revenue
- CVKD N/A
- MNY $71,649,746.00
- Revenue This Year
- CVKD N/A
- MNY $31.98
- Revenue Next Year
- CVKD N/A
- MNY $10.97
- P/E Ratio
- CVKD N/A
- MNY N/A
- Revenue Growth
- CVKD N/A
- MNY N/A
- 52 Week Low
- CVKD $5.70
- MNY $0.55
- 52 Week High
- CVKD $22.90
- MNY $1.86
- Technical
- Relative Strength Index (RSI)
- CVKD 49.98
- MNY 68.06
- Support Level
- CVKD $11.00
- MNY $0.99
- Resistance Level
- CVKD $13.56
- MNY $1.10
- Average True Range (ATR)
- CVKD 1.15
- MNY 0.09
- MACD
- CVKD 0.25
- MNY 0.03
- Stochastic Oscillator
- CVKD 80.97
- MNY 90.91
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.